At the 2023 symposium researchers from the Mass General Brigham community had the opportunity to submit abstracts for consideration to present at the poster session. This platform provided a way for participants to showcase the work they have been doing in the gene and cell therapy field, allowing them to share their research and insights.
Featured Links
Featured Links
Featured Links
Featured Links
Jump to:
Uniting Gene and Cell Therapy Experts
November 12-13, 2024
The Gene and Cell Therapy Institute (GCTI)'s annual research symposium stands as a global hub, drawing in esteemed researchers, accomplished scientists, and industry professionals from across the globe. Together, they share a common goal of disseminating knowledge, unveiling cutting-edge breakthroughs, and envisioning the transformative potential within the realm of gene and cell therapy.
What sets the symposium apart is its commitment to cultivating a unique and collaborative environment. Building on the sucess of the inaugral symposium in 2023 which attracted over 500 registrants and featured keynote speakers Siddhartha Mukherjee, MD, DPhil and R. Jude Samulski, PhD, the 2024 event (November 12-13, 2024) will feature engaging discussions by leading pioneers in gene and cell therapy research and plentiful opportunities for networking and collaboration among attendees.
2024 Gene and Cell Therapy Research Symposium
The 2nd annual Gene and Cell Therapy Research Symposium will take place November 12-13, 2024, bringing together Mass General Brigham researchers and clinicians dedicated to advancing gene and cell therapy.
Members of the Mass General Brigham research community and interested industry will have the opportunity to:
2023 Symposium Highlights
The Gene and Cell Therapy Institute held its inaugural Gene and Cell Therapy Research Symposium in November 2023 in collaboration with the Mass General Research Institute and the Brigham Research Institute. The symposium welcomed approximately 500 registrants, primarily from the Mass General Brigham community. Over the course of the day-long event, Mass General Brigham investigators discussed their research across four areas: viral gene therapy, platform technology, translation and cell therapy.
2023 Keynote Speakers
-
Siddhartha Mukherjee, MD, DPhil | Oncology -
R. Jude Samulski, PhD | AAV Gene Therapy
2023 Speakers, topics and more
Cell Therapy
Allan Goldstein, MD, Massachusetts General Hospital
Marcela Maus, MD, PhD, Massachusetts General Hospital, Gene and Cell Therapy Insitute
Angela Shen, MD, MBA, Mass General Brigham Innovation, Gene and Cell Therapy Institute
Platform Technology
Omar Abudayyeh, PhD, Brigham and Women's Hospital
Natalie Artzi, PhD, Brigham and Women's Hospital
Jonathan Gootenberg, PhD, Brigham and Women's Hospital
Dana Hammill, MS, MBA, Gene and Cell Therapy Institute
Robert Alexander Wesselhoeft, PhD, Gene and Cell Therapy Institute
Translation
Sharl Azar, MD, Massachusetts General Hospital
Florian Eichler, MD, Massachusetts General Hospital
Viral Gene Therapy
Xandra Breakfield, PhD, Massachusetts General Hospital
E. Antonio Chiocca, MD, PhD, Brigham and Women's Hospital
Patricia Musolino, MD, PhD, Massachusetts General Hospital
The 2023 symposium included an overview of the GCTI’s Spark Grant program, which funds gene and cell therapy projects by Mass General Brigham investigators that demonstrate tangible advancements toward clinical applications and commercialization outcomes including licensing, partnerships and new company creation. In its inaugural year the program received 56 proposals from Mass General Brigham investigators, and six grant recipients were each awarded $250,000 to continue their innovative work in disease areas such as Huntington's disease, cancer, chronic pain and deafness.
Contact us
We look forward to seeing you at the 2024 Gene and Cell Therapy Research Symposium!
Members of the Mass General Brigham research community and interested industry can learn more and register here.
Please email us with any questions about how to get involved with the symposium.
